Lam Research (LRCX) Stock Forecast, Price Target & Predictions
LRCX Stock Forecast
Lam Research stock forecast is as follows: an average price target of $649.74 (represents a 794.47% upside from LRCX’s last price of $72.64) and a rating consensus of 'Buy', based on 16 wall street analysts offering a 1-year stock forecast.
LRCX Price Target
The average price target for Lam Research (LRCX) is $649.74 based on 1-year price targets from 16 Wall Street analysts in the past 3 months, with a price target range of $1.15K to $75.00. This represents a potential 794.47% upside from LRCX's last price of $72.64.
LRCX Analyst Ratings
According to 16 Wall Street analysts, Lam Research's rating consensus is 'Buy'. The analyst rating breakdown for LRCX stock is 0 'Strong Buy' (0.00%), 10 'Buy' (62.50%), 6 'Hold' (37.50%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Lam Research Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 24, 2024 | Melissa Weathers | Deutsche Bank | - | - | 2.94% | 3.25% |
| Oct 22, 2024 | Craig Ellis | B.Riley Financial | - | - | 44.15% | 44.55% |
| Oct 22, 2024 | Brian Chin | Stifel Nicolaus | - | - | 44.15% | 44.55% |
| Oct 15, 2024 | Srini Pajjuri | Raymond James | - | - | 16.69% | 37.67% |
| Oct 03, 2024 | Joseph Moore | Morgan Stanley | - | - | -4.71% | 6.00% |
| Sep 20, 2024 | Vijay Rakesh | Mizuho Securities | - | - | 20.39% | 1207.82% |
| Sep 12, 2024 | Timothy Arcuri | UBS | - | - | 52.90% | 1483.15% |
| Sep 12, 2024 | Vijay Rakesh | Mizuho Securities | - | - | 39.82% | 1345.48% |
| Jun 05, 2024 | Tom O'Malley | Barclays | - | - | -2.46% | 1138.99% |
| May 22, 2024 | Joseph Quatrochi | Wells Fargo | - | - | 1.66% | 1249.12% |
The latest Lam Research stock forecast, released on Oct 24, 2024 by Melissa Weathers from Deutsche Bank, set a price target of $75.00, which represents a 2.94% increase from the stock price at the time of the forecast ($72.86), and a 3.25% increase from LRCX last price ($72.64).
Lam Research Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 8 | 20 |
| Avg Price Target | $75.00 | $451.50 | $777.85 |
| Last Closing Price | $72.64 | $72.64 | $72.64 |
| Upside/Downside | 3.25% | 521.56% | 970.83% |
In the current month, the average price target of Lam Research stock is $75.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 3.25% increase as opposed to Lam Research's last price of $72.64. This month's average price target is down -83.39% compared to last quarter, and down -90.36% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 24, 2024 | Wells Fargo | Buy | Buy | Hold |
| Oct 24, 2024 | Cowen & Co. | Buy | Buy | Hold |
| Oct 24, 2024 | B. Riley | Buy | Buy | Hold |
| Oct 24, 2024 | Deutsche Bank | Hold | Hold | Hold |
| Oct 15, 2024 | Raymond James | Outperform | Outperform | Hold |
| Sep 17, 2024 | Wells Fargo | Buy | Buy | Hold |
| Sep 17, 2024 | UBS | Underperform | Underperform | Hold |
| Sep 17, 2024 | Morgan Stanley | Cautious | Cautious | Hold |
| Sep 12, 2024 | UBS | Buy | Buy | Hold |
| Aug 01, 2024 | Cowen & Co. | Buy | Buy | Hold |
Lam Research's last stock rating was published by Wells Fargo on Oct 24, 2024. The company gave LRCX a "Buy" rating, the same as its previous rate.
Lam Research Financial Forecast
Lam Research Revenue Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $3.76B | $3.48B | $3.21B | $3.87B | $5.28B | $5.07B | $4.64B | $4.06B | $4.23B | $4.30B | $4.15B | $3.85B | $3.46B | $3.18B |
| Avg Forecast | $5.60B | $5.53B | $5.36B | $5.35B | $5.34B | $5.21B | $5.05B | $4.87B | $4.75B | $4.64B | $4.47B | $4.35B | $4.32B | $4.06B | $3.82B | $3.72B | $3.71B | $3.42B | $3.13B | $3.82B | $5.10B | $4.92B | $4.21B | $4.25B | $4.41B | $4.32B | $4.03B | $3.72B | $3.34B | $3.11B |
| High Forecast | $5.79B | $5.71B | $5.53B | $5.53B | $5.52B | $5.39B | $5.22B | $5.04B | $4.91B | $4.80B | $4.62B | $4.49B | $4.34B | $4.06B | $3.82B | $3.72B | $3.75B | $3.54B | $3.23B | $3.94B | $5.27B | $4.92B | $4.21B | $4.25B | $4.41B | $4.32B | $4.03B | $3.72B | $3.34B | $3.11B |
| Low Forecast | $5.49B | $5.41B | $5.25B | $5.24B | $5.23B | $5.10B | $4.95B | $4.77B | $4.65B | $4.55B | $4.38B | $4.21B | $4.31B | $4.06B | $3.82B | $3.72B | $3.70B | $3.35B | $3.07B | $3.74B | $5.00B | $4.92B | $4.21B | $4.25B | $4.41B | $4.32B | $4.03B | $3.72B | $3.34B | $3.11B |
| # Analysts | 12 | 7 | 7 | 8 | 8 | 7 | 10 | 7 | 6 | 11 | 6 | 14 | 15 | 7 | 6 | 6 | 13 | 6 | 6 | 6 | 5 | 5 | 5 | 11 | 12 | 11 | 10 | 9 | 10 | 10 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.01% | 1.02% | 1.02% | 1.01% | 1.03% | 1.03% | 1.10% | 0.96% | 0.96% | 1.00% | 1.03% | 1.03% | 1.04% | 1.02% |
Lam Research's average Quarter revenue forecast for Mar 24 based on 6 analysts is $3.72B, with a low forecast of $3.72B, and a high forecast of $3.72B. LRCX's average Quarter revenue forecast represents a -0.97% decrease compared to the company's last Quarter revenue of $3.76B (Dec 23).
Lam Research EBITDA Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 12 | 7 | 7 | 8 | 8 | 7 | 10 | 7 | 6 | 11 | 6 | 14 | 15 | 7 | 6 | 6 | 13 | 6 | 6 | 6 | 5 | 5 | 5 | 11 | 12 | 11 | 10 | 9 | 10 | 10 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.06B | $1.02B | $947.69M | $1.11B | $1.77B | $1.77B | $1.57B | $1.28B | $1.48B | $1.47B | $1.44B | $1.29B | $1.11B | $1.05B |
| Avg Forecast | $1.78B | $1.76B | $1.70B | $1.70B | $1.70B | $1.66B | $1.61B | $1.55B | $1.51B | $1.48B | $1.42B | $1.38B | $1.37B | $1.29B | $1.22B | $1.55B | $1.18B | $1.09B | $995.23M | $1.41B | $1.63B | $1.57B | $1.34B | $1.28B | $1.40B | $1.38B | $1.28B | $1.12B | $1.06B | $988.81M |
| High Forecast | $1.84B | $1.82B | $1.76B | $1.76B | $1.75B | $1.71B | $1.66B | $1.60B | $1.56B | $1.53B | $1.47B | $1.43B | $1.38B | $1.29B | $1.22B | $1.86B | $1.19B | $1.12B | $1.03B | $1.70B | $1.96B | $1.57B | $1.34B | $1.54B | $1.40B | $1.38B | $1.28B | $1.35B | $1.06B | $988.81M |
| Low Forecast | $1.74B | $1.72B | $1.67B | $1.67B | $1.66B | $1.62B | $1.57B | $1.52B | $1.48B | $1.45B | $1.39B | $1.34B | $1.37B | $1.29B | $1.22B | $1.24B | $1.18B | $1.07B | $974.82M | $1.13B | $1.30B | $1.57B | $1.34B | $1.03B | $1.40B | $1.38B | $1.28B | $897.54M | $1.06B | $988.81M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.89% | 0.94% | 0.95% | 0.79% | 1.08% | 1.13% | 1.17% | 0.99% | 1.06% | 1.07% | 1.12% | 1.15% | 1.04% | 1.06% |
6 analysts predict LRCX's average Quarter EBITDA for Mar 24 to be $1.55B, with a high of $1.86B and a low of $1.24B. This is 46.98% upper than Lam Research's previous annual EBITDA (Dec 23) of $1.06B.
Lam Research Net Income Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 12 | 7 | 7 | 8 | 8 | 7 | 10 | 7 | 6 | 11 | 6 | 14 | 15 | 7 | 6 | 6 | 13 | 6 | 6 | 6 | 5 | 5 | 5 | 11 | 12 | 11 | 10 | 9 | 10 | 10 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $954.27M | $887.40M | $802.54M | $814.01M | $1.47B | $1.43B | $1.21B | $1.02B | $1.19B | $1.18B | $1.14B | $1.07B | $869.23M | $823.45M |
| Avg Forecast | $16.90B | $16.48B | $1.61B | $1.59B | $1.57B | $1.53B | $1.45B | $1.37B | $1.31B | $1.27B | $1.19B | $1.15B | $1.15B | $1.05B | $987.90M | $1.25B | $927.88M | $802.09M | $660.73M | $1.14B | $1.31B | $1.26B | $959.74M | $1.04B | $1.12B | $1.08B | $994.80M | $930.35M | $751.38M | $681.17M |
| High Forecast | $17.63B | $17.20B | $1.68B | $1.66B | $1.64B | $1.59B | $1.51B | $1.43B | $1.36B | $1.32B | $1.25B | $1.20B | $1.17B | $1.10B | $1.03B | $1.51B | $960.74M | $836.94M | $689.43M | $1.37B | $1.57B | $1.26B | $959.74M | $1.24B | $1.12B | $1.08B | $994.80M | $1.12B | $751.38M | $681.17M |
| Low Forecast | $16.45B | $16.04B | $1.57B | $1.55B | $1.53B | $1.48B | $1.41B | $1.34B | $1.27B | $1.23B | $1.16B | $1.07B | $1.11B | $1.02B | $961.57M | $1.00B | $910.80M | $780.72M | $643.11M | $912.33M | $1.05B | $1.26B | $959.74M | $829.40M | $1.12B | $1.08B | $994.80M | $744.28M | $751.38M | $681.17M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.03% | 1.11% | 1.21% | 0.71% | 1.12% | 1.14% | 1.26% | 0.99% | 1.07% | 1.09% | 1.15% | 1.15% | 1.16% | 1.21% |
Lam Research's average Quarter net income forecast for Mar 24 is $1.25B, with a range of $1.00B to $1.51B. LRCX's average Quarter net income forecast represents a 31.46% increase compared to the company's last Quarter net income of $954.27M (Dec 23).
Lam Research SG&A Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 12 | 7 | 7 | 8 | 8 | 7 | 10 | 7 | 6 | 11 | 6 | 14 | 15 | 7 | 6 | 6 | 13 | 6 | 6 | 6 | 5 | 5 | 5 | 11 | 12 | 11 | 10 | 9 | 10 | 10 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $228.84M | $207.02M | $199.83M | $193.50M | $233.80M | $205.62M | $210.00M | $217.41M | $236.13M | $222.19M | $217.53M | $203.70M | $218.90M | $189.75M |
| Avg Forecast | $315.99M | $311.75M | $302.18M | $302.02M | $301.30M | $294.04M | $285.10M | $274.97M | $268.00M | $261.99M | $252.27M | $245.53M | $243.49M | $228.94M | $215.68M | $266.92M | $209.61M | $193.12M | $176.60M | $242.65M | $259.14M | $277.76M | $237.63M | $220.59M | $249.07M | $243.87M | $227.38M | $176.93M | $188.39M | $175.37M |
| High Forecast | $326.54M | $322.17M | $312.27M | $312.11M | $311.36M | $303.86M | $294.63M | $284.15M | $276.96M | $270.74M | $260.70M | $253.43M | $244.62M | $229.03M | $215.68M | $320.30M | $211.87M | $199.58M | $182.50M | $291.18M | $310.96M | $277.76M | $237.63M | $264.71M | $249.07M | $243.87M | $227.38M | $212.32M | $188.39M | $175.37M |
| Low Forecast | $309.51M | $305.36M | $295.98M | $295.82M | $295.12M | $288.01M | $279.26M | $269.33M | $262.51M | $256.61M | $247.09M | $237.63M | $242.93M | $228.84M | $215.68M | $213.53M | $209.05M | $189.16M | $172.98M | $194.12M | $207.31M | $277.76M | $237.63M | $176.47M | $249.07M | $243.87M | $227.38M | $141.55M | $188.39M | $175.37M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.09% | 1.07% | 1.13% | 0.80% | 0.90% | 0.74% | 0.88% | 0.99% | 0.95% | 0.91% | 0.96% | 1.15% | 1.16% | 1.08% |
Lam Research's average Quarter SG&A projection for Mar 24 is $266.92M, based on 6 Wall Street analysts, with a range of $213.53M to $320.30M. The forecast indicates a 16.64% rise compared to LRCX last annual SG&A of $228.84M (Dec 23).
Lam Research EPS Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 12 | 7 | 7 | 8 | 8 | 7 | 10 | 7 | 6 | 11 | 6 | 14 | 15 | 7 | 6 | 6 | 13 | 6 | 6 | 6 | 5 | 5 | 5 | 11 | 12 | 11 | 10 | 9 | 10 | 10 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $7.25 | $6.69 | $5.99 | $6.03 | $10.80 | $10.42 | $8.76 | $7.34 | $8.50 | $8.32 | $8.02 | $7.51 | $6.04 | $5.67 |
| Avg Forecast | $12.96 | $12.64 | $1.23 | $1.22 | $1.21 | $1.17 | $1.11 | $1.05 | $1.00 | $0.97 | $0.92 | $0.88 | $0.88 | $0.81 | $0.76 | $0.73 | $0.71 | $0.62 | $0.51 | $0.65 | $1.00 | $0.96 | $0.73 | $0.75 | $0.85 | $0.82 | $0.76 | $0.66 | $0.57 | $0.52 |
| High Forecast | $13.52 | $13.19 | $1.29 | $1.27 | $1.26 | $1.22 | $1.16 | $1.10 | $1.05 | $1.01 | $0.96 | $0.92 | $0.90 | $0.84 | $0.79 | $0.76 | $0.74 | $0.64 | $0.53 | $0.68 | $1.05 | $0.96 | $0.73 | $0.75 | $0.85 | $0.82 | $0.76 | $0.66 | $0.57 | $0.52 |
| Low Forecast | $12.61 | $12.30 | $1.20 | $1.19 | $1.18 | $1.14 | $1.08 | $1.03 | $0.98 | $0.95 | $0.89 | $0.82 | $0.85 | $0.78 | $0.74 | $0.71 | $0.70 | $0.60 | $0.49 | $0.63 | $0.98 | $0.96 | $0.73 | $0.75 | $0.85 | $0.82 | $0.76 | $0.66 | $0.57 | $0.52 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 10.19% | 10.88% | 11.82% | 9.24% | 10.77% | 10.89% | 11.97% | 9.76% | 9.98% | 10.11% | 10.57% | 11.34% | 10.54% | 10.91% |
According to 6 Wall Street analysts, Lam Research's projected average Quarter EPS for Mar 24 is $0.73, with a low estimate of $0.71 and a high estimate of $0.76. This represents a -89.93% decrease compared to LRCX previous annual EPS of $7.25 (Dec 23).
Lam Research Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| LRCX | Lam Research | - | - | 794.47% | Buy |
| AEHR | Aehr Test Systems | - | - | 105.59% | Buy |
| ACLS | Axcelis | - | - | 82.50% | Buy |
| IPGP | IPG Photonics | - | - | 58.12% | Buy |
| ASML | ASML | - | - | 45.08% | Buy |
| TER | Teradyne | - | - | 41.56% | Buy |
| ENTG | Entegris | - | - | 34.20% | Buy |
| KLIC | Kulicke and Soffa Industries | - | - | 32.19% | Hold |
| AMAT | Applied Materials | - | - | 13.95% | Buy |
| PLAB | Photronics | - | - | 2.45% | Buy |
| KLAC | KLA | - | - | -3.21% | Buy |